Prepare for Liver Disease and Tumors Test with tailored flashcards and questions. Get detailed explanations and improve your knowledge. Ace the medical student exam!

Multiple Choice

AFP level raises suspicion for HCC in at-risk patients when above what threshold?

Alpha-fetoprotein helps flag potential hepatocellular carcinoma in people with cirrhosis or chronic liver disease. Lower levels like 20 ng/mL catch many cancers but many benign conditions also raise AFP, so that threshold isn’t specific enough. A higher cut-off, around 200 ng/mL, provides better specificity: when AFP exceeds 200 ng/mL in an at-risk patient, the likelihood of HCC is high enough to justify prompt imaging with contrast-enhanced CT or MRI to look for a tumor. Very high levels (thousands) are more specific but less useful for initial screening because not all HCCs raise AFP that high, and some non-cancer conditions rarely cause such elevations. Remember, AFP alone doesn’t diagnose HCC—imaging is required to confirm.

Alpha-fetoprotein helps flag potential hepatocellular carcinoma in people with cirrhosis or chronic liver disease. Lower levels like 20 ng/mL catch many cancers but many benign conditions also raise AFP, so that threshold isn’t specific enough. A higher cut-off, around 200 ng/mL, provides better specificity: when AFP exceeds 200 ng/mL in an at-risk patient, the likelihood of HCC is high enough to justify prompt imaging with contrast-enhanced CT or MRI to look for a tumor. Very high levels (thousands) are more specific but less useful for initial screening because not all HCCs raise AFP that high, and some non-cancer conditions rarely cause such elevations. Remember, AFP alone doesn’t diagnose HCC—imaging is required to confirm.